|
Re: New Publication Conclusion
|
3
|
Resverlogix Corp.
|
Mar 02, 2023 10:22AM
|
|
Re: Question to ask at the AGM
|
3
|
Resverlogix Corp.
|
Oct 30, 2019 09:42PM
|
|
Re: Potential market
|
3
|
Resverlogix Corp.
|
Nov 17, 2019 03:52PM
|
|
Re: Dr. Ray versus Donald McCaffrey - A huge disconnect...
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 09:34AM
|
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
3
|
Resverlogix Corp.
|
Jul 24, 2020 09:01AM
|
|
Re: Epigentic headline:
|
3
|
Resverlogix Corp.
|
May 01, 2024 02:01PM
|
|
Re: For what it’s worth
|
3
|
Zenith Epigenetics
|
Jul 20, 2023 06:52AM
|
|
Re: Shawn lu RSU and option cancelled
|
3
|
Resverlogix Corp.
|
Apr 07, 2020 11:25AM
|
|
Re: Debt
|
3
|
Zenith Epigenetics
|
Apr 06, 2022 11:38AM
|
|
Re: Would be nice if....
|
3
|
Resverlogix Corp.
|
Jul 29, 2019 11:45AM
|
|
Estimated Glomerular Filtration Rate
|
3
|
Resverlogix Corp.
|
Nov 17, 2019 04:25PM
|
|
Re: Annual and Special Meeting
|
3
|
Resverlogix Corp.
|
Apr 08, 2023 06:43AM
|
|
Additional Reports of Exempt Distribution - 2023-04-28
|
3
|
Resverlogix Corp.
|
May 05, 2023 04:17PM
|
|
Re: Total Shares Outstanding 10/15/20
|
3
|
Resverlogix Corp.
|
Oct 15, 2020 09:59AM
|
|
Re: No news
|
3
|
Resverlogix Corp.
|
Sep 17, 2022 03:37PM
|
|
Entresto VS Apabetalone
|
3
|
Resverlogix Corp.
|
Mar 02, 2020 06:42AM
|
|
Re: Biogen looks to FDA for approval of early Alzheimers drug.
|
3
|
Resverlogix Corp.
|
Oct 22, 2019 10:21AM
|
|
Re: SP 52 week low
|
3
|
Resverlogix Corp.
|
Oct 06, 2022 10:10AM
|
|
Re: New trial
|
3
|
Zenith Epigenetics
|
May 26, 2021 09:35AM
|
|
Re: ACC/WCC Virtual 2020
|
3
|
Resverlogix Corp.
|
Mar 29, 2020 09:20AM
|
